Potential Utility of Therapeutic Drug Monitoring of Adalimumab in Predicting Short-Term Mucosal Healing and Histologic Remission in Pediatric Crohn's Disease Patients

BACKGROUND: Limited data exist regarding mucosal healing (MH) and therapeutic drug monitoring (TDM) in pediatric Crohn's disease (CD) patients treated with adalimumab (ADL). We aimed to investigate the associations between ADL trough levels (TLs) and MH, and between ADL TLs and histologic remis...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Korean Med Sci
Hlavní autoři: Choi, So Yoon, Choi, Young Ok, Choe, Yon Ho, Kang, Ben
Médium: Artigo
Jazyk:Inglês
Vydáno: The Korean Academy of Medical Sciences 2020
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7183843/
https://ncbi.nlm.nih.gov/pubmed/32329259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2020.35.e114
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky